Literature DB >> 3519442

Impairment of lymphocyte proliferative responses and interleukin-2 production in susceptible (C57BL/6) mice infected with Salmonella typhimurium.

M Deschenes, M Guenounou, E Ronco, F Vacheron, C Nauciel.   

Abstract

C57BL/6 (susceptible) and A/J (resistant) mice were infected intravenously with a temperature-sensitive mutant of Salmonella typhimurium. In C57BL/6 mice a marked depression of the proliferative response of spleen cells to B and T mitogens occurred and was maximal at 2-3 weeks post-infection, whereas only minor changes were found in A/J mice. This immunodepression was mediated, at least in part, by adherent cells. Moreover, spleen cells from infected C57BL/6 mice did not produce interleukin-2 (IL-2) after concanavalin A stimulation. The impairment of IL-2 production was not related to a defect in IL-1 release. The addition of IL-2 to spleen cells did not restore their ability to respond to mitogens. The depression of mitogenic responses in infected C57BL/6 mice occurred at a time when increased resistance was present.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3519442      PMCID: PMC1452678     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  20 in total

1.  Biochemical characterization of a factor released by macrophages.

Authors:  H G Opitz; D Niethammer; R C Jackson; H Lemke; R Huget; H D Flad
Journal:  Cell Immunol       Date:  1975-07       Impact factor: 4.868

2.  Characterization of lymphocyte-activating factor (LAF) produced by the macrophage cell line, P388D1. I. Enhancement of LAF production by activated T lymphocytes.

Authors:  S B Mizel; J J Oppenheim; D L Rosenstreich
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

3.  Separation of mouse spleen cells by passage through columns of sephadex G-10.

Authors:  I A Ly; R I Mishell
Journal:  J Immunol Methods       Date:  1974-08       Impact factor: 2.303

4.  Suppression of phytohemagglutinin and lipopolysaccharide responses in mouse spleen cells by Bacillus Calmette-Guerin.

Authors:  E M Allen; V L Moore
Journal:  J Reticuloendothel Soc       Date:  1979-10

5.  Selective lymphoid deletion and generalised lymphoid depletion in mouse typhoid.

Authors:  A E Stuart; J G Collee
Journal:  J Pathol Bacteriol       Date:  1967-10

6.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

7.  Genetics of resistance to infection with Salmonella typhimurium in mice.

Authors:  J Plant; A A Glynn
Journal:  J Infect Dis       Date:  1976-01       Impact factor: 5.226

8.  Host response to infection with a temperature-sensitive mutant of Salmonella typhimurium in a susceptible and a resistant strain of mice.

Authors:  C Nauciel; F Vilde; E Ronco
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

9.  Macrophage-mediated suppression. I. Evidence for participation of both hdyrogen peroxide and prostaglandins in suppression of murine lymphocyte proliferation.

Authors:  Z Metzger; J T Hoffeld; J J Oppenheim
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

10.  The fate of temperature-sensitive salmonella mutants in vivo in naturally resistant and susceptible mice.

Authors:  C E Hormaeche; R A Pettifor; J Brock
Journal:  Immunology       Date:  1981-04       Impact factor: 7.397

View more
  12 in total

Review 1.  Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens.

Authors:  L Cárdenas; J D Clements
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

2.  Prior immunologic experience potentiates the subsequent antibody response when Salmonella strains are used as vaccine carriers.

Authors:  J X Bao; J D Clements
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

3.  Role of H-2 and non-H-2 genes in control of bacterial clearance from the spleen in Salmonella typhimurium-infected mice.

Authors:  C Nauciel; E Ronco; J L Guenet; M Pla
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

4.  Influence of the Ity/Lsh/Bcg gene on the development of suppressor cell precursors in the early phase of the infection of mice with Mycobacterium lepraemurium.

Authors:  D Gosselin; R Turcotte; S Lemieux
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

5.  Diet-induced obese mice exhibit altered immune responses to early Salmonella Typhimurium oral infection.

Authors:  Ricardo Ernesto Ramírez-Orozco; Elena Franco Robles; Victoriano Pérez Vázquez; Joel Ramírez Emiliano; Marco Antonio Hernández Luna; Sergio López Briones
Journal:  J Microbiol       Date:  2018-08-23       Impact factor: 3.422

6.  Unresponsiveness to Con A in spleen cell cultures of M. lepraemurium-infected mice is dependent on a defective expression of high-affinity IL-2 receptors rather than on a lack of IL-2 production.

Authors:  R Turcotte; S Lemieux
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

7.  Specific and natural antibody production during Salmonella typhimurium infection in genetically susceptible and resistant mice.

Authors:  P Matsiota-Bernard; W Mahana; S Avrameas; C Nauciel
Journal:  Immunology       Date:  1993-07       Impact factor: 7.397

8.  Virulent Salmonella typhimurium-induced lymphocyte depletion and immunosuppression in chickens.

Authors:  J O Hassan; R Curtiss
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

9.  Effect of recombinant human interleukin-2 on the course of experimental chronic respiratory tract infection caused by Klebsiella pneumoniae in mice.

Authors:  Y Iizawa; T Nishi; M Kondo; K Tsuchiya; A Imada
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

10.  Antigen-presenting characteristics of peritoneal cells of Salmonella enteritidis 11RX-infected mice.

Authors:  M Pope; I Kotlarski
Journal:  Immunology       Date:  1992-10       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.